Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod

BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC)...